bpc-157 human clinical trials evidence safety regulatory status review BPC- 157 Here's a nice graphic on
Description
Gao R, Gao Z, Huang L, Qin H
It formally identified these compounds as presenting potential safety risks and rendered them entirely ineligible for routine compounding

The economy is unmistakably slowing down , but not necessarily going into a recession
Dosing is typically 250-500mcg twice daily for injectable, or 500-1,000mcg daily for oral